Navigation Links
United Therapeutics Corporation Reports Third Quarter 2010 Financial Results
Date:10/28/2010

SILVER SPRING, Md., Oct. 28 /PRNewswire-FirstCall/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its results of operations for the quarter ended September 30, 2010.

Total revenues for the third quarter of 2010 were $171.0 million, up from $97.2 million for the same quarter in 2009. Net income for the third quarter of 2010 was $39.7 million, or $0.70 per basic share, compared to net income of $11.9 million, or $0.22 per basic share, for the same quarter in 2009. Gross margin from sales was $148.9 million for the third quarter of 2010, compared to $84.2 million for the same quarter last year. Earnings before non-cash charges, a non-GAAP financial measure(1), was $99.1 million for the third quarter of 2010 compared to $40.6 million for the third quarter of 2009.  

"We had a good quarter as the demand for our core products continues to grow," said Martine Rothblatt, Ph.D., United Therapeutics' Chairman and Chief Executive Officer. "Having approvals for multiple products is making a positive difference in our growth rate and in the number of patients that we can help compared to last year."

(1) See definition of earnings before non-cash charges and a reconciliation of net income to earnings before non-cash charges below.

Financial Results for the Three Months Ended September 30, 2010RevenuesThe following table sets forth the components of net revenues (dollars in thousands):Three Months Ended
September 30,20102009Percentage Change Cardiopulmonary products:Remodulin$

109,584$

87,40025.4%Tyvaso48,7175,113852.8%Adcirca9,9351,514556.2%Telemedicine services and products2,4082,904(17.1)%Other33928419.4%Total net revenues$

170,983$

97,21575.9%The growth in revenues for the three months ended September 30, 2010 reflects the continued increase in the number of patients being prescri
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Baxter Announces Licensing Agreement for Innocolls Gentamicin Surgical Implant in the United States
2. InVitria Further Strengthens Sales Team with Promotion of Brandy Sargent to Account Manager - Western United States
3. JD Technologies, LLC Selected by FCT Ingenieurkeramik GmbH to Represent Their High Performance Ceramic Expertise In the United States
4. United Therapeutics to Announce Third Quarter 2008 Financial Results Before Market Open on Thursday, October 30, 2008
5. International Drug & Explosive Detection Firm Identa Corp Releasing: Jant Pharmacal Corporation Reports Successful Market Penetration of the Accutest(R) IDenta Co-brand in the United States and Oversees
6. Lilly Announces Launch of Color Differentiation System for Humalog(R) and Humulin(R) U-100 Insulin Products in the United States
7. Results of United Kingdom MRSA Surveillance Program Using Cepheid GeneXpert(R) System Demonstrate Benefits of Rapid Testing
8. Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009
9. United Therapeutics Reports Third Quarter 2008 Financial Results
10. Lilly Contributes $11.1 Million to United Way Annual Campaign
11. First United Kingdom Patients Treated With Percutaneous MitraClip(R) System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... DIEGO , May 16, 2013  The registration ... of Bioscience Financial Officers (ABFO) 2013 National Conference, the ... be held May 28-31 at the Hilton San Diego ... touches on this year,s conference and want to make ... to attend," said Brandi Roberts , ...
(Date:5/16/2013)... May 16, 2013 As the weather warms, ... their favorite Spring looks. While most make a statement with ... many women find the warmer weather mixes makeup and sweat ... with the onset of acne during warmer months, Adult ... acne treatment users the best ways to deter breakouts. ...
(Date:5/16/2013)... NEW YORK , May 16, ... a new market research report is ...   Competitor Analysis: ... Biosuperiors http://www.reportlinker.com/p01171947/Competitor-Analysis-Therapeutic-Proteins-–-Biosimilars-Biobetters--Biosuperiors.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical ...   The ...
(Date:5/16/2013)... 2013 BioInformatics LLC New Market Report ... Cell-Derived Cells: Current and Future Opportunities (13-004) , ... in the primary cells market continues to increase. In ... used most often, how satisfied scientists are with commercially ... anticipated growth rate. ,  , Additionally, terminally differentiated ...
Breaking Biology Technology:Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 3Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 4Adult Acne Treatment, Probiotic Action Shares New Tips for Women on How to Fight Acne While Wearing Makeup 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 4Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 5Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 6Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 7Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 8BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004) 2BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004) 3
... - Johnson & Johnson Diabetes Institute Launched ... Key Role in Halting Escalating,Disease in the EMEA ... the number of people with diabetes,will have increased ... within Eastern,Mediterranean and Middle Eastern populations and 80 ...
... Sept. 24 InVitria,( http://www.InVitria.com ) addressed ... Cell Culture Development" Conference on,September 15-16 in ... optimizing cell culture media using its product ... ), In a presentation of scientific ...
... (Nasdaq: MATK ) --,Martek Biosciences Corporation ... sole source supply agreement with Grupo Ricap. Martek ... produced by Grupo Ricap in,Mexico. Grupo Ricap is ... & life,sARA(TM) will initially be available in infant,formula ...
Cached Biology Technology:Health Experts Call for New Strategies to Combat Alarming Rise in Diabetes 2Health Experts Call for New Strategies to Combat Alarming Rise in Diabetes 3Health Experts Call for New Strategies to Combat Alarming Rise in Diabetes 4InVitria Touts Product Advantages at Cambridge's Cell Culture Conference 2Martek to be the Sole Source Supplier of DHA and ARA for Infant Formulas Produced By Grupo Ricap 2
(Date:5/16/2013)... years old give unprecedented insight into the evolutionary ... most species-rich groups among the modern bony fishes. ... from the Division of Paleontology and Geobiology at ... Ludwig-Maximilians-Universitaet (LMU) in Munich / Germany have completed ... assign to the group of bony fishes that ...
(Date:5/16/2013)... Cameroon and the manager of San Diego Zoo Global,s ... Whitley award. The Whitley award is an international ... it celebrates the extraordinary achievements of some of the ... was selected for the award due to his efforts ... its wildlife inhabitants., HRH The Princess Royal, the charity,s ...
(Date:5/15/2013)... studies touting its benefit in moderating gout risk, new ... does not reduce uric acid (urate) levels to a ... C supplementation, alone or in combination with allopurinol, appears ... levels in gout patients according to the results published ... Arthritis & Rheumatism . , Gout is an ...
Breaking Biology News(10 mins):Paleontology: The eloquence of the otoliths 2Paleontology: The eloquence of the otoliths 3Cameroon researcher wins prestigious 'Green Oscar' 2Cameroon researcher wins prestigious 'Green Oscar' 3Vitamin C does not lower uric acid levels in gout patients 2
... Academies today announced the recipients of their 2009 Communication ... INITIATIVE, these prestigious awards recognize excellence in reporting and ... With support from the W.M. Keck Foundation, the ... This year,s winners will be honored during a ...
... Boston, with the Broad Institute and Harvard Medical School, ... National Institute of Mental Health as part of the ... with autism, using new technologies for rapid DNA sequencing ... grant, part of the federal stimulus package, officially starts ...
... of Massachusetts Medical School today announced the beginning of ... activity of a human monoclonal antibody (MAB) developed to ... being conducted at the King Edward Memorial Hospital in ... of India, which is working in a collaborative partnership ...
Cached Biology News:Academies announce winners of 2009 Communication Awards 2Academies announce winners of 2009 Communication Awards 3Stimulus grant to fund whole-genome sequencing in children with autism 2Stimulus grant to fund whole-genome sequencing in children with autism 3First human gets new antibody aimed at rabies virus 2First human gets new antibody aimed at rabies virus 3
For testing the AQUA technique on your MS instruments....
Our original highly-purified, robust Taq Polymerase which delivers consistently high yields and minimal background...
A formulation of our Biolase DNA Polymerase which contains a Red Loading Dye...
... assay (ELISA) test kits are qualitative ... the detection of drugs and/or their metabolites ... for forensic use only. It is recommended ... a quantitative method such as GC/MS. ...
Biology Products: